https://www.youtube.com/watch?v=n2umVX2XzJE
At the tail-end of the March 15, 2023 Palo Alto PD support group meeting, a Stanford study recruiting for Parkinson's Disease (PD), progressive supranuclear

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078665/
Progressive Supranuclear Palsy (PSP) and Parkinson's Disease (PD), especially in their early stages, show overlapping clinical manifestations. The criteria for the diagnosis of PSP, released in 2017, indicate four basic features of the disease—postural instability (P), akinesia (A), oculomotor dysfunction (O) and cognitive and lingual

https://stanfordhealthcare.org/medical-conditions/brain-and-nerves/progressive-supranuclear-palsy.html
Progressive supranuclear palsy is rare. Only about one in 100,000 Americans has the disorder. PSP may be easily mistaken for Parkinson's disease, which is much more common, because the conditions share many of the same symptoms. But with PSP, speech and difficulty swallowing are usually affected more significantly than with Parkinson's disease.

https://parkinsonsblog.stanford.edu/2017/08/diagnosing-progressive-supranuclear-palsy/
August 15, 2017 By Parkinson's Community Help. Stanford Movement Disorders Center is kicking off a webinar series. Join us for a free, one-hour webinar on diagnosing progressive supranuclear palsy (PSP), the most common atypical parkinsonism disorder. The speaker is Stanford movement disorders specialist Kathleen Poston, MD.

https://parkinsonsblog.stanford.edu/2020/07/parkinsons-disease-compared-to-atypical-parkinsonism-disorders-webinar-notes/
Her presentation focused on atypical parkinsonism disorders as a whole and the differences between Parkinson's Disease (PD) and these atypicals. Of all the atypical parkinsonism disorders, she spent the most time on progressive supranuclear palsy and multiple system atrophy, just a bit of time on Lewy body dementia, and almost no time on

https://brainresilience.stanford.edu/research/funded-research/tracking-parkinson-s-disease-transformer-models-everyday-looking-behaviors
For instance, PD patients are known to have problems for perceiving colors, objects, and motion. We hypothesize that from behaviors of looking during the daily activities, like walking or doing house chores, we can detect abnormalities in neurodegenerative patient groups using machine learning algorithms.

https://www.stanfordchildrens.org/en/topic/default?id=progressive-supranuclear-palsy-134-65
Progressive supranuclear palsy (PSP) is a complex condition that affects the brain. Progressive means that symptoms will keep getting worse over time. Supranuclear refers to the part of the brain affected by the disorder. It's the section above small areas called nuclei in the brainstem. Palsy is a disorder that results in weakness of certain

https://parkinsonsblog.stanford.edu/2020/06/status-of-research-in-pd-is-there-hope-webinar-notes/
June 11, 2020 By Lauren Stroshane. In early June, Stanford Parkinson's Community Outreach offered a webinar on the current status of research on PD, featuring Brent Bluett, DO, a movement disorders specialist at Stanford. He covered research efforts so far in PD, what is in the near-term and long-term pipelines for PD treatment, and how

https://med.stanford.edu/neurology/divisions/md/curepsp.html
While these groups are focused on Parkinson's Disease (PD), those with PSP, CBD, or MSA are also welcome. Visit the Stanford Parkinson's webpage of PD support groups to learn the contact info for the group leaders. PSP, CBD, and MSA - Best National Resources. Brain Support Network, based in California Contact: phone 650-814-0848, email

https://www.americanbrainfoundation.org/diseases/progressive-supranuclear-palsy/
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder that damages parts of the brain associated with thinking and movement. PSP causes a range of symptoms, including difficulty with coordination and muscle movements, particularly the muscles around the eyes. In some cases it can also lead to behavioral symptoms like

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802400/
Model of the clinical trajectory of progressive supranuclear palsy (PSP) Hypothetical model for the pathological-clinical continuum of PSP. PSP is defined as a continuum of disease from a presymptomatic phase (presymptomatic PSP) through a suggestive phase (soPSP) to a fully symptomatic stage that in many cases would meet the full research criteria for PSP-Richardson's syndrome (PSP-RS) or

https://www.ninds.nih.gov/health-information/disorders/progressive-supranuclear-palsy-psp
Progressive supranuclear palsy (PSP) is a rare neurological disorder that affects body movements, walking and balance, and eye movements. PSP is caused by damage to nerve cells in areas of the brain that control thinking and body movements. It is one of a family of neurological conditions called atypical parkinsonism and belongs to the category

https://www.pspassociation.org.uk/wp-content/uploads/2020/10/PSPA-Professionals-Guide-A5-LR-Final.pdf
8 Difference between PSP and Parkinson's disease 9 Standards of Care 13 A snapshot of the symptoms of PSP 22 Planning ahead 24 The professionals guide to PSP template 25 Glossary of terms 27 Feedback opportunity 2 This guide has been developed following a commitment to review and update the 'Pathway of Care for PSP. A guide for Health

https://www.medlink.com/articles/progressive-supranuclear-palsy-cognitive-and-behavioral-changes
Key points. • Patients with progressive supranuclear palsy are more likely to progress faster if they have poorer baseline performance on cognitive tests. This is particularly true of the PSP-Richardson syndrome variant and the PSP-behavioral variant, where mean survival is about 7 years, compared to 11 years for the milder "brainstem

https://link.springer.com/article/10.1007/s00415-021-10511-y
Background Although several progressive supranuclear palsy (PSP) phenotypes have recently been described, studies identifying cognitive and neuropsychiatric differences between them are lacking. Methods An extensive battery of cognitive and behavioural assessments was administered to 63 PSP patients, 25 PD patients with similar sociodemographic characteristics, and 25 healthy controls. We

https://pubmed.ncbi.nlm.nih.gov/33704556/
Background: Although several progressive supranuclear palsy (PSP) phenotypes have recently been described, studies identifying cognitive and neuropsychiatric differences between them are lacking. Methods: An extensive battery of cognitive and behavioural assessments was administered to 63 PSP patients, 25 PD patients with similar sociodemographic characteristics, and 25 healthy controls.

https://www.researchgate.net/publication/349990394_Cognitive_and_behavioral_profile_of_progressive_supranuclear_palsy_and_its_phenotypes
Abstract. Background Although several progressive supranuclear palsy (PSP) phenotypes have recently been described, studies iden. tifying cognitive and neuropsychiatric differences between them

https://www.thelancet.com/journals/laneur/article/PIIS1474442202001618/fulltext
This review provides an update on progressive supranuclear palsy (PSP, or Steele-Richardson-Olszewski disease), an adult-onset neurodegenerative disorder characterised by early postural instability, which leads to falls, and a vertical supranuclear-gaze palsy. Recent epidemiological studies have shown that the disorder is more common than previously recognised, that it is commonly misdiagnosed

https://stanfordhealthcare.org/medical-conditions/brain-and-nerves/progressive-supranuclear-palsy/diagnosis.html
A careful evaluation of symptoms can diagnose progressive supranuclear palsy (PSP), but PSP is difficult to diagnose in its early stages. Often, it may mimic either Parkinson's disease or an inner ear infection, because balance is so affected—diagnosis usually includes ruling out other conditions. Balance problems and changes in gait are the

https://parkinsonsdisease.net/clinical/progressive-supranuclear-palsy
Progressive supranuclear palsy (PSP) is not Parkinson's disease (PD), but is a Parkinsonian-like syndrome.PSP is a rare brain disorder that causes serious and progressive problems with gait and balance, as well as eye movement and thinking problems. 1 It gets its name because it begins slowly and continues to get worse (progressive), it causes weakness (palsy) by damaging certain parts of the

https://neurosciences.ucsd.edu/centers-programs/movement-disorders/community/disease-overview/psp.html
Progressive Supranuclear Palsy (PSP) is a progressive parkinsonian disease that is often misdiagnosed as Parkinson's disease or Alzheimer's disease due to the overlap of its symptoms. PSP is the most common atypical parkinsonian disorder. It gets its name from the brain lesions that occur that control the eye movement.

https://radiopaedia.org/articles/progressive-supranuclear-palsy-1
Progressive supranuclear palsy is characterized by decreased cognition, abnormal eye movements (supranuclear vertical gaze palsy), postural instability and falls, as well as Parkinsonian features and speech disturbances 1-3 . It can be divided into a variety of subtypes many of which overlap with other neurodegenerative diseases that share an

https://movementdisorders.ufhealth.org/for-patients/clinics/uf-progressive-supranuclear-palsy-atypical-parkinsonism-clinic/
Increased awareness and knowledge of PSP and Atypical Parkinson disorders to promote early diagnosis, care, support and access to research and the latest treatments. Centers that provide comprehensive, multi- or interdisciplinary care, support, education and research opportunities for patients and families suffering from PSP/Atypical Parkinson